Menovo(SH:603538)2023-04-28 16:00Financial Performance - The company's operating revenue for Q1 2023 was ¥246,318,328.09, representing a decrease of 50.76% compared to the same period last year[4] - The net profit attributable to shareholders was ¥43,448,818.81, down 62.30% year-on-year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥11,890,801.07, a decline of 89.08% compared to the previous year[4] - Basic earnings per share were ¥0.21, down 72.37% from the previous year[4] - Diluted earnings per share were ¥0.20, a decrease of 71.43% compared to the same period last year[4] - The weighted average return on net assets was 2.06%, a decrease of 4.31 percentage points year-on-year[4] - Total revenue for Q1 2023 was ¥246,318,328.09, a decrease of 50.8% compared to ¥500,209,863.60 in Q1 2022[18] - Net profit for Q1 2023 was ¥46,218,606.15, a decline of 63.6% from ¥126,813,489.39 in Q1 2022[19] - Operating profit for Q1 2023 was ¥56,064,797.51, down 60.9% from ¥143,525,351.09 in Q1 2022[19] Cash Flow and Liquidity - The net cash flow from operating activities was -¥16,639,241.51, reflecting a decrease of 131.60% year-on-year[4] - In Q1 2023, the cash inflow from operating activities was CNY 279,804,657.39, a decrease of 27.6% compared to CNY 386,525,685.65 in Q1 2022[22] - The net cash flow from operating activities was negative at CNY -16,639,241.51, contrasting with a positive CNY 52,664,102.21 in the same period last year[22] - Cash inflow from investment activities totaled CNY 291,138,530.74, significantly higher than CNY 94,579,344.47 in Q1 2022[22] - The net cash flow from investment activities was CNY -101,092,484.23, slightly improved from CNY -101,364,941.96 in Q1 2022[22] - Cash inflow from financing activities was CNY 138,468,439.40, down from CNY 196,935,200.00 in the previous year[23] - The net cash flow from financing activities was CNY 23,574,767.30, a decrease of 58.6% compared to CNY 56,829,526.44 in Q1 2022[23] - The cash and cash equivalents at the end of Q1 2023 stood at CNY 468,943,485.90, compared to CNY 380,939,246.25 at the end of Q1 2022[23] Assets and Liabilities - Total assets at the end of the reporting period were ¥4,427,481,086.30, an increase of 0.18% from the end of the previous year[5] - Total assets as of Q1 2023 were ¥4,427,481,086.30, slightly up from ¥4,419,458,473.75 at the end of Q1 2022[16] - Total liabilities decreased to ¥2,198,904,259.95 in Q1 2023 from ¥2,246,218,288.08 in Q1 2022, a reduction of 2.1%[16] - The company's cash and cash equivalents decreased to RMB 677,394,093.81 from RMB 791,943,106.69, representing a decline of about 14.4%[14] - The company's receivables, including accounts receivable, decreased to RMB 151,742,630.92 from RMB 168,844,670.64, a reduction of about 10.1%[14] Shareholder Information - The top shareholder, Ningbo Meinuohua Holding Group Co., Ltd., holds 21.22% of the shares, totaling 45,285,661 shares[11] - The second-largest shareholder, Yao Chengzhi, owns 5.66% of the shares, amounting to 12,070,253 shares[11] - The company reported a total of 9,080,630 shares held through margin trading by major shareholders[12] Operational Insights - The decrease in revenue was primarily due to a reduction in COVID-related orders and the exclusion of Liao Yuan Pharmaceutical from the consolidated financial statements[8] - The company has plans for market expansion and new product development, although specific details were not disclosed in the report[12] - Research and development expenses for Q1 2023 were ¥11,580,047.95, an increase of 35.9% from ¥8,531,863.08 in Q1 2022[19] - The company plans to focus on market expansion and new product development in the upcoming quarters[19] Inventory and Current Assets - As of March 31, 2023, the company's total current assets amounted to RMB 1,924,253,063.05, an increase from RMB 1,894,382,271.16 at the end of 2022, reflecting a growth of approximately 1.9%[14] - The company's inventory increased to RMB 648,072,367.50, up from RMB 594,415,030.12, indicating a rise of approximately 9.0%[14] - The total non-current assets reached RMB 2,113,000,000, with significant investments in fixed assets totaling RMB 1,250,877,425.99[14] - The total amount of trading financial assets increased to RMB 308,899,668.81 from RMB 217,377,643.31, reflecting a growth of approximately 42.2%[14]